These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 16432143

  • 1. Inflammatory, immune, and viral aspects of inclusion-body myositis.
    Dalakas MC.
    Neurology; 2006 Jan 24; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J, Rakocevic G, Raju R, Dalakas MC.
    Brain; 2004 May 24; 127(Pt 5):1182-90. PubMed ID: 15047591
    [Abstract] [Full Text] [Related]

  • 6. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
    Dalakas MC, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M.
    Ann Neurol; 2007 May 24; 61(5):466-75. PubMed ID: 17366634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N, Engel AG.
    Neurology; 2008 Feb 05; 70(6):418-24. PubMed ID: 17881720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cellular mechanisms in inflammatory myopathies.
    Hohlfeld R, Goebels N, Engel AG.
    Baillieres Clin Neurol; 1993 Nov 05; 2(3):617-35. PubMed ID: 8156145
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC.
    Curr Opin Neurol; 2004 Oct 05; 17(5):561-7. PubMed ID: 15367860
    [Abstract] [Full Text] [Related]

  • 14. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.
    Dalakas MC.
    Nat Clin Pract Neurol; 2006 Aug 05; 2(8):437-47. PubMed ID: 16932602
    [Abstract] [Full Text] [Related]

  • 15. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC.
    Neuropathol Appl Neurobiol; 2011 Apr 05; 37(3):226-42. PubMed ID: 21155862
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V, Engel WK, Yang CC, Alvarez RB, Lee VM, Wisniewski T.
    Am J Pathol; 1998 Apr 05; 152(4):889-95. PubMed ID: 9546349
    [Abstract] [Full Text] [Related]

  • 18. Sporadic inclusion body myositis: counts of different types of abnormal fibers.
    Pruitt JN, Showalter CJ, Engel AG.
    Ann Neurol; 1996 Jan 05; 39(1):139-43. PubMed ID: 8572661
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.